Multi-modal Quantitative Imaging of the Skin

Launched by HJN SVERIGE AB/NEKO HEALTH · May 16, 2025

Keywords

ClinConnect Summary

This clinical trial, called "Multi-modal Quantitative Imaging of the Skin," is exploring a new imaging technology that can help screen for and detect skin-related diseases, including skin cancer, psoriasis, and diabetic foot issues. The goal is to see if this advanced imaging can be useful for checking the skin and identifying problems early on.

The trial is currently looking for adult participants aged 65 to 74 who are receiving regular healthcare at the study sites or have been invited to join. To participate, individuals must be able to understand the study information and give their consent. However, those with severe health issues, cognitive impairments, or difficulties with balance may not be eligible. If you decide to join, you can expect to undergo some imaging tests that will help researchers learn more about your skin health. Overall, this study aims to improve early detection and treatment of skin diseases, which could potentially benefit many patients.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Adult patients that are part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation.
• • Patients with signed informed consent
• Exclusion criteria:
• • Cognitive impairment
• • Patients unable to understand the oral and written study information in Swedish or English
• • Other severe disorder or terminal disease
• • Patients unable to provide an informed consent
• • Patients not able to keep balance, while standing up with closed eyes, without any aid
• • Claustrophobic patients